PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-438.75%
Negative net income growth while CRK stands at 68.63%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-11.24%
Both reduce yoy D&A, with CRK at -41.43%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
147.62%
Well above CRK's 69.26% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
154.17%
SBC growth while CRK is negative at -9.07%. John Neff would see competitor possibly controlling share issuance more tightly.
-21400.00%
Negative yoy working capital usage while CRK is 155.92%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-100.00%
Both yoy AR lines negative, with CRK at -347.38%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21400.00%
Negative yoy usage while CRK is 101.33%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-101.55%
Both negative yoy, with CRK at -11.38%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-52.86%
Negative yoy CFO while CRK is 166.49%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
8.33%
Lower CapEx growth vs. CRK's 48.11%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-93.52%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
2206.45%
Purchases growth of 2206.45% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-80.38%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
10.70%
Growth of 10.70% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-178.01%
We reduce yoy invests while CRK stands at 15.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
33.33%
Debt repayment growth of 33.33% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.